Instytut Ekspertyz Toksykologicznychsp. z o.o.

Other technical testing and analysis

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-03-02
Share capital
5,000.00 PLN
Registered address
ul. Marii Curie-Skłodowskiej 55/61/306, 50-369 Wrocław, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2025, 9 days late).

  • 202524/07/2026
  • 202414/07/2025
  • 202321/06/2024
  • 202204/07/2023
  • 202107/07/2022
  • 202021/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 290.65kMedianUSD 191.00kAverageUSD 829.70k
Net profit
This companyUSD 15.71kMedianUSD 8.71kAverageUSD 60.13k
Operating costs
This companyUSD 274.93kMedianUSD 157.35kAverageUSD 771.61k
Assets
This companyUSD 151.34kMedianUSD 143.09kAverageUSD 797.88k

Public procurement

Instytut Ekspertyz Toksykologicznych is the contractor in one public sector contract, worth USD 7.19k.

SubjectAmount
Provision of services involving the analysis of urine samples for the presence of psychoactive and psychotropic substances
$7,185

Authorized Representatives

Marcin Zawadzki – Management Board Member
Paweł Szpot – Management Board Member

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently

Ownership

OwnerSharesShare valueStake
Paweł Szpotage 39
50$675.3150%
Marcin Zawadzkiage 47
50$675.3150%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-04-01.

  • mBank
    92 1140 2004 0000 3902 7672 3261

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $1,577,565.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,118
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,118
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$0

European Funds

ProjectEU co-financing
Development of the innovative “COMBITOX” platform for toxicological diagnosis of drug addiction, medication dependence and alcoholism
$1.6M

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Qsense sp. z o.o.sp. k.
Aparatura Medycznasp. z o.o.
Mediatissp. z o.o.
BARG Dolny Śląsksp. z o.o.
Novasellsp. z o.o.
Venturolabsp. z o.o.
Instytut Techniki Motoryzacyjnejsp. z o.o.
Waderasp. z o.o.
Qsensesp. z o.o.
Qsense Groupsp. z o.o.

Change history

DateEvent
2025-06-16Address change
2018-05-24PKD change
2017-03-02Entered in the register

FAQ

Last updated: 2026-07-27